SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-049820
Filing Date
2022-09-14
Accepted
2022-09-14 08:00:13
Documents
1
Period of Report
2022-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5136
  Complete submission text file 0001209191-22-049820.txt   6776
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
Chambers Michael Andrew (Reporting) CIK: 0001932527 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14895 | Film No.: 221242090